www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade since 2007, without exception, is included in the performance results. Number of winning positions: 162 Number of losing positions: 10 Average annualized
www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade since 2007, without exception, is included in the performance results. Number of winning positions: 162 Number of losing positions: 10 Average annualized
www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade since 2007, without exception, is included in the performance results. Number of winning positions: 162 Number of losing positions: 10 Average annualized
www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade since 2007, without exception, is included in the performance results. Number of winning positions: 162 Number of losing positions: 10 Average annualized
Based on ZYX Change Method, we shorted flu stocks. We have now taken profits on all of these stocks with the exception of $BCRX. Our proprietary money flow indicators are beginning to turn up, therefore ZYX Change Method discipline dictates an exit. For performance tracking purposes, we will use Friday’s
We are buying to cover $AVAV. Friday’s closing price is $25.33. Our original short was based on the thesis that drone business has become more competitive and margins are declining while the Wall Street stays enamored with the apparent sexiness of drones killing terrorists. FY2011 defense budget submission creates more
We are exiting $BCRX and $AVAV; please see separate posts for the reasons. We are short on $ACOR with average price of $30.28. Our thesis has not changed in that Ampyra is not a very good drug, although Wall Street has termed it a blockbuster drug. . In the short
Consider short sell on $ABX with scale ins right here at $39.45. Stop zone over $41.16. With IMF sales of gold looming and dollar getting stronger, macro picture is not favorable in the very short term. After earnings this morning the stock is technically overbought. There was nothing in the
Our Multi-Asset Global Allocation Model has been 20% long on US junk bonds since Oct 26, 2009. We have also been 10% long on US Senior Bank Loans. This allocation has not only contributed high single digits yield bu, but also capital gains. Senior Bank Loans have provided 15% capital
www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade since 2007, without exception, is included in the performance results. Number of winning positions: 162 Number of losing positions: 10 Average annualized